To date, the open innovation approach has been implemented successfully in the chemicals and automotive industries. Life science sectors such as pharmaceuticals, cosmetics, food and biotechnology are now using this strategy in various ways and with various degrees of porosity. more
Dr. Udo Bock
Bock Project Management
Udo Bock studied chemistry at Saarland University, receiving his doctorate in 1996 in the discipline of pharmaceutical chemistry. His post-doc work included time spent on a joint research project with MUCOS Pharma GmbH & Co. KG at the Department of Biopharmaceutics and Pharmaceutical Technology at Saarland University. Positions held from 1998 to 2014 included Laboratory Manager In Vitro ADME, Sales Director and CTO at the certified (GLP, GMP) service provider Across Barriers GmbH. He completed an IHK Leadership course at the University of Koblenz/Landau and the Zurich University of Applied Sciences from 2007 to 2008. His research work focuses on the establishment and validation of in vitro methods for bioavailability and safety classification, as well as the downscaling and miniaturization of semisolid dosage forms. He has been an active board member of the Risk Assessment and Regulatory Affairs Committee within the German Society for Dermopharmacy since 2009. After forming Bock Project Management in April 2014, he has since been collaborating with companies in the life sciences sector on preclinical, clinical and regulatory projects.